Ontrak (OTRK) Competitors $0.56 -0.02 (-2.95%) As of 02:12 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock OTRK vs. BGLC, MGRX, SSY, VSEE, DHAC, ATIP, ACON, NIVF, BACK, and BTTXShould you be buying Ontrak stock or one of its competitors? The main competitors of Ontrak include BioNexus Gene Lab (BGLC), Mangoceuticals (MGRX), SunLink Health Systems (SSY), VSee Health (VSEE), Digital Health Acquisition (DHAC), ATI Physical Therapy (ATIP), Aclarion (ACON), NewGenIvf Group (NIVF), IMAC (BACK), and Better Therapeutics (BTTX). These companies are all part of the "healthcare" industry. Ontrak vs. Its Competitors BioNexus Gene Lab Mangoceuticals SunLink Health Systems VSee Health Digital Health Acquisition ATI Physical Therapy Aclarion NewGenIvf Group IMAC Better Therapeutics BioNexus Gene Lab (NASDAQ:BGLC) and Ontrak (NASDAQ:OTRK) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends, media sentiment and profitability. Is BGLC or OTRK more profitable? BioNexus Gene Lab has a net margin of -22.85% compared to Ontrak's net margin of -274.20%. BioNexus Gene Lab's return on equity of -24.18% beat Ontrak's return on equity.Company Net Margins Return on Equity Return on Assets BioNexus Gene Lab-22.85% -24.18% -20.14% Ontrak -274.20%-269.88%-128.35% Which has better valuation and earnings, BGLC or OTRK? BioNexus Gene Lab has higher earnings, but lower revenue than Ontrak. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioNexus Gene Lab$9.51M0.92-$1.60MN/AN/AOntrak$10.85M0.22-$25.49M-$15.81-0.04 Which has more risk & volatility, BGLC or OTRK? BioNexus Gene Lab has a beta of 5.08, indicating that its share price is 408% more volatile than the S&P 500. Comparatively, Ontrak has a beta of 2.16, indicating that its share price is 116% more volatile than the S&P 500. Do analysts recommend BGLC or OTRK? Ontrak has a consensus price target of $24.00, indicating a potential upside of 4,132.80%. Given Ontrak's stronger consensus rating and higher possible upside, analysts clearly believe Ontrak is more favorable than BioNexus Gene Lab.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioNexus Gene Lab 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Ontrak 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor BGLC or OTRK? In the previous week, BioNexus Gene Lab and BioNexus Gene Lab both had 1 articles in the media. Ontrak's average media sentiment score of 1.89 beat BioNexus Gene Lab's score of 1.87 indicating that Ontrak is being referred to more favorably in the news media. Company Overall Sentiment BioNexus Gene Lab Very Positive Ontrak Very Positive Do insiders & institutionals hold more shares of BGLC or OTRK? 18.9% of BioNexus Gene Lab shares are held by institutional investors. Comparatively, 13.0% of Ontrak shares are held by institutional investors. 0.7% of BioNexus Gene Lab shares are held by insiders. Comparatively, 1.9% of Ontrak shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. SummaryBioNexus Gene Lab beats Ontrak on 7 of the 13 factors compared between the two stocks. Get Ontrak News Delivered to You Automatically Sign up to receive the latest news and ratings for OTRK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OTRK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OTRK vs. The Competition Export to ExcelMetricOntrakMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.36M$3.78B$5.71B$9.51BDividend YieldN/A1.33%4.60%3.99%P/E Ratio-0.0432.7028.0720.02Price / Sales0.22126.47459.47103.02Price / CashN/A22.4036.5558.97Price / Book0.244.388.615.88Net Income-$25.49M$189.47M$3.24B$258.50M7 Day Performance1.25%1.74%3.83%2.03%1 Month Performance-42.08%-3.74%10.40%12.52%1 Year Performance-84.94%-2.86%34.13%19.07% Ontrak Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OTRKOntrak3.1368 of 5 stars$0.57-3.0%$24.00+4,147.8%-85.2%$2.38M$10.85M-0.04250Positive NewsBGLCBioNexus Gene Lab1.2027 of 5 stars$4.94-3.1%N/A-4.1%$8.89M$9.51M0.0030Gap DownMGRXMangoceuticals1.0601 of 5 stars$1.72+3.6%N/A-98.1%$8.89M$620K-0.373Gap UpSSYSunLink Health Systems2.5911 of 5 stars$1.24+6.9%N/A+55.2%$8.73M$31.09M8.861,376News CoverageDividend AnnouncementGap UpHigh Trading VolumeVSEEVSee Health1.1594 of 5 stars$1.37+1.5%$5.00+265.0%-56.1%$4.93MN/A0.00N/AGap UpDHACDigital Health AcquisitionN/A$1.35-3.6%N/A-62.8%$4.87MN/A0.002,021Gap DownATIPATI Physical TherapyN/A$1.03flatN/A-94.2%$4.54M$741.86M-0.065,600ACONAclarion2.9836 of 5 stars$7.32+2.8%$11,758.50+160,535.2%-99.7%$4.25M$50K0.007NIVFNewGenIvf GroupN/A$0.54-5.1%N/A-99.7%$2.33M$5.43M0.00N/ANegative NewsGap UpBACKIMACN/A$0.06-35.0%N/A-96.7%$125K$72.05K0.00180Gap DownBTTXBetter TherapeuticsN/AN/AN/A-66.7%$5KN/A0.0040 Related Companies and Tools Related Companies BGLC Competitors MGRX Competitors SSY Competitors VSEE Competitors DHAC Competitors ATIP Competitors ACON Competitors NIVF Competitors BACK Competitors BTTX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OTRK) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ontrak, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ontrak With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OTRK Stock Alerts